nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells
|
Mwangi, Kennedy W. |
|
|
199 |
1 |
p. 207-214 |
artikel |
2 |
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
|
Fiascarelli, Alessio |
|
|
199 |
1 |
p. 13-23 |
artikel |
3 |
A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
|
Murata, Takeshi |
|
|
199 |
1 |
p. 57-66 |
artikel |
4 |
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
|
Oswald, Ailsa J. |
|
|
199 |
1 |
p. 35-46 |
artikel |
5 |
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil
|
Mazzonetto, Patricia |
|
|
199 |
1 |
p. 127-136 |
artikel |
6 |
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study
|
van Hemert, Annemiek K. E. |
|
|
199 |
1 |
p. 81-89 |
artikel |
7 |
Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
|
Dix-Peek, Thérèse |
|
|
199 |
1 |
p. 1-12 |
artikel |
8 |
Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
|
Mamtani, Anita |
|
|
199 |
1 |
p. 119-126 |
artikel |
9 |
History of infertility and risk of breast cancer: a prospective cohort study
|
Farland, Leslie V. |
|
|
199 |
1 |
p. 185-193 |
artikel |
10 |
Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants
|
Liu, Xuejing |
|
|
199 |
1 |
p. 25-33 |
artikel |
11 |
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases
|
Chew Minmin, S. |
|
|
199 |
1 |
p. 99-107 |
artikel |
12 |
Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score
|
Ebner, Florian |
|
|
199 |
1 |
p. 173-184 |
artikel |
13 |
mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women’s circle of health study
|
Ilozumba, Mmadili N. |
|
|
199 |
1 |
p. 137-146 |
artikel |
14 |
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study
|
Tsai, Jui-Hung |
|
|
199 |
1 |
p. 47-55 |
artikel |
15 |
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study
|
Jiang, Hanfang |
|
|
199 |
1 |
p. 67-79 |
artikel |
16 |
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
|
Scott, Oliver William |
|
|
199 |
1 |
p. 195-206 |
artikel |
17 |
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
|
Hurson, Amber N. |
|
|
199 |
1 |
p. 147-154 |
artikel |
18 |
The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors
|
Brown, Justin C. |
|
|
199 |
1 |
p. 109-117 |
artikel |
19 |
Treatment-related side effects among Hispanic and non-Hispanic white long-term breast cancer survivors by tamoxifen use and duration
|
Dibble, Kate E. |
|
|
199 |
1 |
p. 155-172 |
artikel |
20 |
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
|
Taylor, Caitlin |
|
|
199 |
1 |
p. 91-98 |
artikel |